The Endocrine System: Comprehensive Study Notes

Intercellular Communication and Hormonal Mechanisms

  • Endocrine System Overview

    • Composed of endocrine cells and tissues that synthesize and release approximately 3030 different hormones (chemical messengers).

    • Functions primarily to control, integrate, and coordinate long-term physiological processes throughout the body.

  • Mechanisms of Intercellular Communication

    • Direct Communication

      • Involves the direct exchange of ions and small molecules between adjacent cells across gap junctions.

      • Occurs exclusively between two cells of the same cell type.

      • Highly specialized and relatively rare in the human body.

    • Paracrine Communication

      • Uses chemical signals (paracrines) to transfer information from cell to cell within a single local tissue.

    • Autocrine Communication

      • Chemical messengers (autocrines) exert their effects on the exact same cells that secreted them.

      • Example: Prostaglandins secreted by smooth muscle cells trigger contraction of those same smooth muscle cells.

    • Endocrine Communication

      • Endocrine cells release chemical messengers (hormones) directly into extracellular fluid, which then enter the bloodstream.

      • Hormones travel via circulation to alter the metabolic activities of multiple target organs and tissues simultaneously.

      • Regulates long-term developmental processes such as physical growth, tissue differentiation, and reproductive maturation.

    • Synaptic Communication

      • Neurons release neurotransmitters across a specialized physical gap (synapse) directly to target cells.

      • Leads to action potentials propagated along axons, enabling high-speed transmission to specific, localized destinations.

      • Ideal for immediate crisis management and rapid bodily responses.

  • Target Cells and Hormonal Action

    • Target cells express specific protein receptors required to bind and read incoming hormonal messages.

    • Hormones adjust cellular activities by changing the types, quantities, or catalytic activities of key enzymes and structural proteins.

  • Comparison of Endocrine and Nervous Systems

    • Shared Features:

      • Both systems rely on the release of chemical signals that bind to specific target cell receptors.

      • Both share common chemical messengers (e.g., epinephrine and norepinephrine).

      • Both are controlled primarily by negative feedback regulatory loops.

      • Both function to preserve physiological homeostasis by coordinating cellular activities.

    • Distinguishing Features:

      • Endocrine cells release secretions into extracellular fluid (unlike exocrine cells, which secrete onto epithelial surfaces or into ducts).

      • Endocrine organs are structurally scattered throughout the body rather than continuous.

Chemical Classes of Hormones

  • Amino Acid Derivatives (Biogenic Amines)

    • Small molecules structurally related to specific amino acids.

    • Derivatives of Tyrosine:

      • Thyroid hormones: Synthesized by the thyroid gland.

      • Catecholamines: Epinephrine (EE), Norepinephrine (NENE), and Dopamine.

    • Derivatives of Tryptophan:

      • Serotonin and Melatonin.

  • Peptide Hormones

    • Chains of amino acids; typically synthesized as inactive precursor molecules termed prohormones, which are converted into active hormones before or after secretion.

    • Glycoproteins:

      • Proteins exceeding 200200 amino acids in length with carbohydrate side chains.

      • Examples: Thyroid-stimulating hormone (TSHTSH), Luteinizing hormone (LHLH), and Follicle-stimulating hormone (FSHFSH).

    • Short Polypeptides and Small Proteins:

      • Short-chain polypeptides: Antidiuretic hormone (ADHADH) and Oxytocin (OXTOXT), both consisting of 99 amino acids.

      • Small proteins: Insulin (5151 amino acids), Growth hormone (GHGH, 191191 amino acids), and Prolactin (PRLPRL, 198198 amino acids).

      • Includes all hormones secreted by the hypothalamus, heart, thymus, digestive tract, pancreas, and posterior lobe of the pituitary gland.

  • Lipid Derivatives

    • Eicosanoids:

      • Molecules derived from arachidonic acid, a 2020-carbon fatty acid.

      • Function primarily as paracrines that coordinate local cellular activities and enzymatic processes (such as blood clotting).

      • Leukotrienes: Eicosanoids with secondary roles as hormones.

      • Prostaglandins: Coordinate local tissue activity; converted into thromboxanes and prostacyclins in specific target tissues.

    • Steroid Hormones:

      • Lipid structures derived from cholesterol.

      • Examples: Androgens (produced by testes), Estrogens and Progesterone (produced by ovaries), Corticosteroids (produced by adrenal cortex), and Calcitriol (produced by kidneys).

      • Circulate bound to specific plasma transport proteins, allowing them to remain in circulation significantly longer than peptide hormones.

Hormone Transport, Receptors, and Signal Transduction

  • Hormone Transport and Inactivation

    • Hormones circulate either as free molecules or bound to specialized carrier proteins.

    • Free Hormones:

      • Remain functional for less than 11\,hour.

      • Inactivated when they:

        1. Diffuse out of the bloodstream and bind to receptors on target cells.

        2. Are absorbed and broken down by liver or kidney cells.

        3. Are enzymatically degraded by enzymes in blood plasma or interstitial fluids.

    • Thyroid and Steroid Hormones:

      • Remain in circulation for much longer periods.

      • Greater than 99%99\% become attached to specific transport proteins in the blood.

      • Exist in a state of dynamic equilibrium between free and bound forms, creating a substantial hormone reserve in the bloodstream.

  • Receptor Dynamics

    • Hormone binding alters genetic activity, rates of protein synthesis, or plasma membrane permeability.

    • Down-regulation:

      • High concentrations of a hormone trigger a decrease in the total number of its specific receptors.

      • Renders target cells less sensitive to elevated hormone levels.

    • Up-regulation:

      • Low concentrations of a hormone trigger an increase in the total number of its specific receptors.

      • Renders target cells more sensitive to deficient hormone levels.

  • Extracellular Receptors and Second Messenger Cascades

    • Mechanism Location:

      • Catecholamines and peptide hormones are not lipid-soluble and cannot cross the plasma membrane.

      • They bind to extracellular receptors on the outer surface of the plasma membrane.

    • First and Second Messengers:

      • First Messenger: The hormone binding to the cell surface receptor.

      • Second Messenger: An intracellular intermediary (e.g., cAMPcAMP, cGMPcGMP, Ca2+Ca^{2+}) released due to the hormone-receptor interaction that alters cellular metabolic rates.

    • Amplification:

      • Binding of a few hormone molecules to surface receptors generates thousands of second messengers inside the cell, magnifying the target cell response.

    • G Proteins:

      • Enzyme complexes coupled to membrane receptors that bind GTPGTP and serve as the physical link between first and second messengers.

    • The Cyclic AMP (cAMPcAMP) Pathway:

      1. Activated G protein activates the enzyme adenylate cyclase.

      2. Adenylate cyclase converts ATPATP into cyclic AMP (cAMPcAMP).

      3. cAMPcAMP acts as a second messenger to activate protein kinases.

      4. Kinases phosphorylate target proteins, accelerating or inhibiting metabolic pathways.

      5. Phosphodiesterase (PDEPDE) rapidly inactivates cAMPcAMP by converting it into AMPAMP.

      • Hormones using cAMPcAMP: Epinephrine, Norepinephrine, Calcitonin, Parathyroid hormone, ADHADH, ACTHACTH, FSHFSH, LHLH, and TSHTSH (Note: G protein activation can also decrease cAMPcAMP levels to cause cellular inhibition).

    • The Calcium Ion (Ca2+Ca^{2+}) Pathway:

      1. Activated G protein activates the enzyme phospholipase C (PLCPLC).

      2. PLCPLC triggers a receptor cascade generating diacylglycerol (DAGDAG) and inositol triphosphate (IP3IP_3) from membrane phospholipids.

      3. IP3IP_3 diffuses into the cytoplasm and stimulates the release of stored Ca2+Ca^{2+} from intracellular reserves (such as the endoplasmic reticulum).

      4. Activation of protein kinase C (PKCPKC) opens cell-membrane calcium channels, admitting extracellular Ca2+Ca^{2+}.

      5. Ca2+Ca^{2+} binds to calmodulin, which activates downstream intracellular enzymes.

      • Hormones using Ca2+Ca^{2+}: Epinephrine, Norepinephrine, Oxytocin, hypothalamic regulatory hormones, and several eicosanoids.

  • Intracellular Receptors and Direct Gene Activation

    • Steroid Hormones:

      • Lipid-soluble; diffuse directly across plasma membrane lipids.

      • Bind to cytoplasmic or nuclear receptors.

      • The hormone-receptor complex binds directly to target sites on nuclear DNA, activating specific genes to increase transcription (mRNAmRNA production), protein synthesis, and alteration of cellular structure and activity.

    • Thyroid Hormones:

      • Transported across the plasma membrane into the cytoplasm.

      • Bind to receptors located on mitochondria, directly accelerating cellular ATPATP production.

      • Bind to receptors in the nucleus, activating specific genes to alter protein synthesis and metabolic rate.

  • Control of Hormone Secretion

    • Primarily governed by negative feedback loops, where the cellular response decreases the intensity of the original stimulus.

    • Stimuli Types:

      • Humoral Stimuli: Changes in the chemical composition of extracellular fluid (e.g., controls secretion in heart, pancreas, parathyroid glands, and digestive tract).

      • Hormonal Stimuli: Arrival or removal of specific controlling hormones; often involves multi-step cascades.

      • Neural Stimuli: Arrival of neurotransmitters at neuroglandular junctions (e.g., highest control exerted by the hypothalamus).

The Hypothalamus and Pituitary Gland

  • Anatomy of the Pituitary Gland (Hypophysis)

    • Nestled within the sella turcica of the sphenoid bone; isolated from the cranial cavity by the sellar diaphragm.

    • Connected to the inferior surface of the hypothalamus by the infundibulum.

    • Releases nine major peptide hormones, all of which bind to extracellular membrane receptors and utilize cAMPcAMP as a second messenger.

  • Mechanisms of Hypothalamic Control

    1. Synthesizes ADHADH (in supra-optic nuclei) and OXTOXT (in paraventricular nuclei) and transports them along axons to the posterior pituitary for release.

    2. Secretes regulatory hormones into a local portal system to govern anterior pituitary lobe secretions.

    3. Contains autonomic nervous centers that exert direct neural control over the adrenal medulla via preganglionic sympathetic fibers.

  • The Hypophyseal Portal System

    • Median Eminence: Swelling at the base of the infundibulum where hypothalamic neurosecretory neurons release regulatory hormones into fenestrated capillaries.

    • Blood Flow Pathway:

      • Superior hypophyseal artery delivers blood to the primary capillary bed in the upper infundibulum.

      • Portal vessels carry blood containing regulatory hormones directly to the secondary capillary network in the anterior pituitary lobe.

      • Ensures regulatory signals reach target cells in the anterior lobe without being diluted in the systemic circulation.

      • Inferior hypophyseal artery supplies blood directly to the posterior pituitary lobe.

      • Hypophyseal veins drain blood and pituitary hormones into systemic circulation.

  • Anterior Lobe of the Pituitary Gland (Adenohypophysis)

    • Subdivided into three distinct structural regions: pars distalis, pars tuberalis, and pars intermedia.

    • Regulated by two classes of hypothalamic regulatory hormones:

      • Releasing Hormones (RHRH): Stimulate synthesis and secretion of anterior lobe hormones.

      • Inhibiting Hormones (IHIH): Suppress synthesis and secretion of anterior lobe hormones.

  • Hormones of the Anterior Pituitary Lobe

    • Thyroid-Stimulating Hormone (TSHTSH): Released in response to Thyrotropin-Releasing Hormone (TRHTRH); targets the thyroid gland to release thyroid hormones.

    • Adrenocorticotropic Hormone (ACTHACTH): Released in response to Corticotropin-Releasing Hormone (CRHCRH); targets the adrenal cortex to release glucocorticoids.

    • Gonadotropins: Released in response to Gonadotropin-Releasing Hormone (GnRHGnRH).

      • Follicle-Stimulating Hormone (FSHFSH): Promotes follicle development in females and sperm maturation in males; regulated by inhibin feedback.

      • Luteinizing Hormone (LHLH): Induces ovulation and progesterone/estrogen secretion in females; stimulates androgen (testosterone) production in males.

      • Hypogonadism: Clinical condition resulting from abnormally low production of gonadotropins.

    • Prolactin (PRLPRL): Stimulates mammary gland development and milk production; inhibited by Prolactin-Inhibiting Hormone (PIHPIH) and stimulated by Prolactin-Releasing Hormone (PRHPRH).

    • Growth Hormone (GHGH / Somatotropin):

      • Regulated by Growth Hormone–Releasing Hormone (GHRHGH-RH) and Growth Hormone–Inhibiting Hormone (GHIHGH-IH).

      • Stimulates liver cells to release somatomedins (insulin-like growth factors), which increase amino acid uptake and protein synthesis in skeletal muscle fibers and other tissues.

      • Stimulates cell division in epithelial and connective tissue stem cells.

      • Stimulates lipid breakdown in adipocytes (glucose-sparing effect).

      • Stimulates glycogen breakdown in the liver, increasing blood glucose levels (diabetogenic effect).

    • Melanocyte-Stimulating Hormone (MSHMSH):

      • Secreted by the pars intermedia; stimulates melanocyte melanin synthesis.

      • Nonfunctional in healthy adult humans except during pregnancy or in specific disease states.

  • Posterior Lobe of the Pituitary Gland (Neurohypophysis)

    • Contains unmyelinated axons of neurosecretory cells whose cell bodies reside in hypothalamic nuclei.

    • Antidiuretic Hormone (ADHADH / Vasopressin):

      • Synthesized by supra-optic nuclei.

      • Released in response to osmoreceptor stimulation (high blood osmotic concentration) or low blood pressure/volume.

      • Targets the kidneys to decrease water loss in urine and causes peripheral vasoconstriction.

    • Oxytocin (OXTOXT):

      • Synthesized by paraventricular nuclei.

      • Released in response to sensory stimulation (e.g., labor pains, infant suckling).

      • Females: Triggers uterine smooth muscle contractions during labor and milk ejection from mammary glands during lactation.

      • Males: Triggers smooth muscle contraction in the ductus deferens and prostate gland.

The Thyroid Gland

  • Anatomy and Histology

    • Positioned immediately inferior to the thyroid cartilage of the larynx.

    • Consists of right and left lobes connected across the anterior trachea by a narrow isthmus.

    • Highly vascularized by the superior and inferior thyroid arteries and drained by superior, middle, and inferior thyroid veins.

    • Thyroid Follicles:

      • Hollow spheres lined by simple cuboidal epithelium composed of follicle cells.

      • Surrounded by dense capillary networks that supply nutrients and trace minerals.

      • Follicle cavity contains a dense, viscous fluid called colloid.

    • C (Clear) Cells / Parafollicular Cells:

      • Endocrine cells situated in the interstitial spaces between thyroid follicles.

  • Synthesis and Secretion of Thyroid Hormones

    1. Iodide ions (II^{-}) are absorbed from the digestive tract, delivered via bloodstream, and actively transported into follicle cells by a TSHTSH-sensitive ion pump.

    2. Iodide ions diffuse to the apical surface of follicle cells where they are oxidized to iodine atoms (I0I^{0}) and attached to tyrosine amino acid residues of thyroglobulin (a protein synthesized by follicle cells and stored in colloid).

    3. Iodine-linked tyrosine residues pair together within thyroglobulin to form:

      • Thyroxine (T4T_4 / Tetraiodothyronine): Contains four iodine atoms.

      • Triiodothyronine (T3T_3): Contains three iodine atoms.

    4. Under TSHTSH stimulation, follicle cells endocytose thyroglobulin from the colloid cavity.

    5. Lysosomal enzymes break down thyroglobulin, releasing free T3T_3, T4T_4, and amino acids into the cytoplasm.

    6. Free T3T_3 and T4T_4 diffuse across the cell membrane into adjacent capillaries.

    7. Transport in blood:

      • 75%75\% of circulating T4T_4 and 70%70\% of T3T_3 bind to thyroid-binding globulins (TBGs).

      • Most remaining hormones bind to transthyretin or albumin.

      • Unbound, active free fractions constitute only 0.3%0.3\% of total T3T_3 and 0.03%0.03\% of total T4T_4.

  • Functions and Physiological Effects of Thyroid Hormones

    • TSHTSH binding to plasma membrane receptors activates key synthesis enzymes; absolute absence of TSHTSH causes thyroid follicles to become completely inactive.

    • Thyroid hormones enter target cells via specific membrane transport systems and exert direct metabolic control:

      • Calorigenic Effect: Accelerates cellular energy consumption and heat generation by upregulating glycolytic and ATPATP production pathways.

      • Significantly elevates oxygen consumption and basal metabolic rate (BMRBMR).

      • Increases heart rate, force of contraction, and systemic blood pressure.

      • Increases target cell sensitivity to sympathetic stimulation.

      • Maintains normal sensitivity of brainstem respiratory centers to oxygen and carbon dioxide concentrations.

      • Stimulates red blood cell production (erythropoiesis) and mineral turnover in bone tissue.

      • Essential for normal skeletal, muscular, and nervous system development in children.

  • Calcitonin (CTCT)

    • Secreted by C (parafollicular) cells in response to elevated plasma calcium concentrations (Ca2+Ca^{2+}).

    • Functions as a physiological antagonist to parathyroid hormone (PTHPTH).

    • Target response: Stimulates Ca2+Ca^{2+} excretion by the kidneys and suppresses Ca2+Ca^{2+} absorption in the digestive tract.

The Parathyroid Glands and Calcium Homeostasis

  • Anatomy and Histology

    • Two pairs of small glands (four total, weighing an aggregate 1.61.6\,g) embedded in the posterior surfaces of the thyroid gland lobes.

    • Histology reveals two primary cell populations: parathyroid (principal) cells and oxyphil cells.

  • Parathyroid Hormone (PTHPTH / Parathormone)

    • Secreted by principal cells in response to abnormally low blood Ca2+Ca^{2+} concentrations.

    • Direct antagonist to calcitonin.

    • Major Actions:

      1. Stimulates osteoclast activity, accelerating bone matrix breakdown and Ca2+Ca^{2+} release into blood.

      2. Enhances renal reabsorption of Ca2+Ca^{2+}, significantly reducing loss in urine.

      3. Stimulates kidney production and release of calcitriol, which promotes active calcium and phosphate absorption in the digestive tract.

  • Homeostatic Regulation of Blood Calcium

    • Normal Blood Calcium Range: 8.5118.5-11\,mg/dL.

    • Hypercalcemia Response (Ca^{2+} > 11\,mg/dL):

      • Receptors: Thyroid C cells release Calcitonin.

      • Effectors: Kidneys excrete excess Ca2+Ca^{2+}; digestive tract decreases Ca2+Ca^{2+} absorption due to reduced calcitriol.

      • Result: Blood Ca2+Ca^{2+} drops back to normal homeostatic baseline.

    • Hypocalcemia Response (Ca^{2+} < 8.5\,mg/dL):

      • Receptors: Parathyroid principal cells release PTHPTH.

      • Effectors: Kidneys reabsorb Ca2+Ca^{2+}; osteoclasts breakdown bone matrix; kidneys synthesize calcitriol to enhance intestinal absorption.

      • Result: Blood Ca2+Ca^{2+} rises back to normal homeostatic baseline.

The Adrenal Glands

  • Anatomy and Vascularization

    • Pyramid-shaped organs lying along the superior border of each kidney.

    • Supplied with arterial blood via superior, middle, and inferior adrenal arteries; drained by adrenal veins.

    • Divided into an outer adrenal cortex and an inner adrenal medulla.

  • Adrenal Cortex Zones and Hormones

    • Stores lipids (especially cholesterol and fatty acids) to synthesize steroid hormones (corticosteroids).

    • Zona Glomerulosa (Outer Region):

      • Produces mineralocorticoids, primarily aldosterone.

      • Function: Stimulates renal reabsorption of sodium (Na+Na^{+}) and water, and accelerates urinary excretion of potassium (K+K^{+}); increases salt receptor sensitivity in taste buds.

      • Regulation: Secreted in response to low blood Na+Na^{+}, low blood volume, low blood pressure, or high blood K+K^{+} (stimulated directly by Angiotensin II; inhibited by natriuretic peptides ANPANP/BNPBNP).

    • Zona Fasciculata (Middle Region):

      • Produces glucocorticoids (primarily cortisol, corticosterone, and cortisone).

      • Function: Accelerates hepatic glucose synthesis and glycogen formation; mobilizes free fatty acids from adipose tissue and amino acids from skeletal muscle; promotes peripheral tissue lipid utilization; exerts strong anti-inflammatory effects by suppressing white blood cell activities.

      • Regulation: Stimulated by ACTHACTH from the anterior pituitary lobe; glucocorticoids exert negative feedback control over hypothalamic CRHCRH and pituitary ACTHACTH release.

    • Zona Reticularis (Inner Region adjacent to Medulla):

      • Forms a narrow, branching cellular network that secretes small quantities of adrenal androgens under ACTHACTH stimulation.

      • Function: Stimulates pre-pubertal pubic hair development in males and females; converted into active estrogens in the general circulation.

  • Adrenal Medulla

    • Secretory activities are directly controlled by preganglionic fibers of the sympathetic division of the autonomic nervous system (ANSANS).

    • Contains two functional types of neuroendocrine cells:

      • 7580%75-80\% of medullary output is Epinephrine (EE).

      • 2025%20-25\% of medullary output is Norepinephrine (NENE).

    • Physiological Response to Medullary Activation:

      • Skeletal Muscles: Mobilizes glycogen reserves and accelerates glycolytic breakdown.

      • Adipose Tissue: Breaks down stored triglycerides into free fatty acids for release into blood.

      • Liver: Breaks down glycogen into glucose for release into circulation.

      • Heart: Stimulates cardiac β1\beta_1 receptors, increasing heart rate and myocardial force of contraction.

The Pineal Gland

  • Anatomy and Histology

    • Positioned in the posterior roof portion of the third ventricle of the brain.

    • Contains specialized secretory cells called pinealocytes.

  • Melatonin Functions

    • Synthesizes and secretes the hormone melatonin.

    • Functions to:

      1. Establish and regulate circadian rhythms (sleep-wake cycles).

      2. Inhibit reproductive functions by suppressing hypothalamic GnRHGnRH secretion.

      3. Protect CNS tissues against cellular damage caused by free radicals.

The Pancreas and Blood Glucose Regulation

  • Anatomy of the Pancreas

    • Elongated organ lying within the loop formed between the inferior border of the stomach and the proximal portion of the small intestine (duodenum).

    • Positioned primarily retroperitoneally; structurally divided into a head, body, and tail.

  • Exocrine vs. Endocrine Pancreas

    • Exocrine Pancreas:

      • Comprises roughly 99%99\% of total pancreatic volume.

      • Consists of pancreatic acini and associated ducts that secrete alkaline, digestive enzyme-rich fluid into the pancreatic duct and duodenum.

    • Endocrine Pancreas:

      • Comprises roughly 1%1\% of pancreatic volume.

      • Consists of cell clusters known as pancreatic islets (islets of Langerhans).

      • Alpha (α\alpha) Cells: Produce glucagon.

      • Beta (β\beta) Cells: Produce insulin.

      • Delta (δ\delta) Cells: Produce a peptide hormone identical to GHIHGH-IH (somatostatin).

      • Pancreatic Polypeptide (PP) Cells: Produce pancreatic polypeptide (PPPP).

  • Hormonal Actions of Insulin and Glucagon

    • Insulin:

      • Released by β\beta cells in response to elevated blood glucose levels.

      • Effects: Accelerates target cell glucose uptake and utilization; enhances intracellular ATPATP production; stimulates glycogen synthesis in liver and skeletal muscle; stimulates amino acid absorption and protein synthesis; accelerates triglyceride synthesis in adipocytes.

    • Glucagon:

      • Released by α\alpha cells in response to decreased blood glucose levels.

      • Effects: Accelerates glycogen breakdown in skeletal muscle and liver; accelerates triglyceride breakdown in adipose tissue; stimulates hepatic glucose synthesis and release (gluconeogenesis).

  • Homeostatic Regulation of Blood Glucose

    • Normal Blood Glucose Range: 7011070-110\,mg/dL.

    • Hyperglycemia Response (Blood glucose $> 110\,mg/dL):\n * Receptors: Pancreatic islet \beta cells release **Insulin**.\n * Effectors: All body cells increase glucose transport, utilization, and glycogen/lipid storage.\n * Result: Blood glucose concentration drops back to normal homeostatic baseline.\n * **Hypoglycemia Response** (Blood glucose $< 70\,mg/dL):

      • Receptors: Pancreatic islet α\alpha cells release Glucagon.

      • Effectors: Liver, muscle, and adipose tissue break down glycogen, fat, and synthesize new glucose.

      • Result: Blood glucose concentration rises back to normal homeostatic baseline.

  • Diabetes Mellitus

    • Pathological state characterized by severe hyperglycemia that exceeds the glucose reabsorption threshold of the renal tubules, resulting in glucosuria (glucose in urine) and polyuria (excessive urine production volume).

    • Type 1 Diabetes Mellitus:

      • Characterized by inadequate or absent insulin production due to autoimmune destruction of pancreatic β\beta cells.

      • Accounts for approximately 5%5\% of all diabetes cases; typically develops during childhood or young adulthood.

      • Requires daily exogenous insulin injections or continuous infusion.

    • Type 2 Diabetes Mellitus:

      • Most common form; characteristically displays normal or elevated circulating insulin levels initially.

      • Target tissues display reduced sensitivity to hormone action (insulin resistance).

      • Strongly associated with obesity; dietary modification and weight loss are highly effective treatments.

    • Clinical Complications of Diabetes:

      • Progressive kidney degeneration (diabetic nephropathy).

      • Retinal microvascular damage (diabetic retinopathy) leading to blindness.

      • Early onset peripheral vascular disease and heart attacks (353-5 times higher risk).

      • Peripheral nerve damage (diabetic neuropathies).

      • Peripheral tissue necrosis due to impaired blood flow, leading to ulcerations, severe infections, and limb amputations.

Secondary Endocrine Organs and Functions

  • Intestines (Digestive System)

    • Secrete numerous local hormones (e.g., secretin, CCK, gastrin) that coordinate digestive tract motility, enzymatic secretion, glucose metabolism, and appetite control.

  • Kidneys (Urinary System)

    • Calcitriol Synthesis Pathway:

      • Cholecalciferol (Vitamin D3D_3) is ingested or synthesized in the epidermal layer of skin under UV light exposure.

      • Converted in the liver to an intermediate form.

      • PTHPTH stimulates kidney enzymes to convert the intermediate into active calcitriol.

      • Calcitriol acts on the digestive tract to stimulate intestinal absorption of calcium (Ca2+Ca^{2+}) and phosphate (PO43PO_4^{3-}) ions.

    • Erythropoietin (EPOEPO):

      • Released in response to reduced renal blood flow or hypoxia (low oxygen levels).

      • Stimulates red blood cell production in red bone marrow.

    • Renin-Angiotensin-Aldosterone System (RAASRAAS):

      • Kidneys release the enzyme renin in response to low blood volume/pressure.

      • Renin converts plasma angiotensinogen to angiotensin I.

      • In lung capillaries, angiotensin-converting enzyme (ACE) converts angiotensin I to angiotensin II.

      • Angiotensin II: Stimulates adrenal secretion of aldosterone, triggers pituitary secretion of ADHADH, stimulates hypothalamic thirst centers, and induces systemic vasoconstriction to elevate blood volume and pressure.

  • Heart (Cardiovascular System)

    • Produces Natriuretic Peptides—Atrial Natriuretic Peptide (ANPANP) and Brain Natriuretic Peptide (BNPBNP)—when excessive blood volume stretches cardiac chamber walls.

    • Actions: Oppose angiotensin II; promote renal loss of Na+Na^{+} and water, inhibit renin/aldosterone secretion, and reduce total blood volume and blood pressure.

  • Thymus (Lymphatic System)

    • Secretes a blend of hormones collectively called thymosins.

    • Promotes the functional development and maturation of T lymphocytes; the thymus undergoes progressive atrophy during adulthood.

  • Gonads (Reproductive System)

    • Testes (Male):

      • Interstitial Endocrine Cells: Synthesize and secretes androgens (primarily testosterone).

      • Nurse (Sertoli) Cells: Support sperm cell physical maturation and secrete inhibin, which suppresses pituitary FSHFSH secretion via negative feedback.

    • Ovaries (Female):

      • Follicle cells produce estrogens (principally estradiol) and inhibin.

      • Following ovulation, remaining follicular cells reorganize into the corpus luteum, which secretes progesterone and estrogens to prepare the uterus for implantation.

  • Adipose Tissue

    • Secretes the peptide hormone leptin.

    • Provides negative feedback control of appetite at the hypothalamic level.

    • Maintains normal physiological levels of GnRHGnRH and gonadotropin synthesis.

Hormone Interactions, Growth, and General Adaptation Syndrome

  • Interactive Effects Between Hormones

    • Antagonistic Effect: Two hormones exert opposing actions; cellular response depends on the functional concentration balance between them (e.g., Insulin vs. Glucagon).

    • Synergistic Effect: Two hormones act together to produce an additive or multiplied total response.

    • Permissive Effect: The presence of a first hormone is strictly necessary for a second hormone to exert its physiological effect.

    • Integrative Effect: Hormones produce different, but complementary, metabolic results in separate tissues.

  • Hormonal Requirements for Normal Growth

    • Growth Hormone (GHGH): Promotes muscle and skeletal growth in children; maintains blood glucose and lipid mobilization in adults.

    • Thyroid Hormones: Critical for CNS development; absence during fetal life or the first post-natal year causes irreversible developmental delay; reduction before puberty halts normal skeletal elongation.

    • Insulin: Essential for facilitating target cell uptake of glucose and amino acids required for cellular growth.

    • Parathyroid Hormone (PTHPTH) and Calcitriol: Promote continuous absorption and deposition of calcium salts into the bone matrix; deficiencies lead to weak, flexible bones.

    • Reproductive Hormones: Stimulate targeted cell growth and differentiation, producing gender-specific skeletal proportions and secondary sex characteristics.

  • Stress and the General Adaptation Syndrome (GAS)

    • Stress Definition: Any environmental or physical condition that threatens homeostatic balance.

    • General Adaptation Syndrome (Stress Response): Divided into three sequential phases:

      1. Alarm Phase:

        • Immediate physiological response directed by the sympathetic division of the ANSANS; dominant hormone is epinephrine.

        • Mobilizes immediate energy reserves (primarily glucose) to support